Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel
· Delayed Price · Currency is ILS · Price in ILA 98.00
-1.20 (-1.21%)
Apr 29, 2026, 3:14 PM IDT
Novolog (Pharm-Up 1966) Revenue
In the year 2025, Novolog (Pharm-Up 1966) had annual revenue of 1.81B ILS, down -10.70%. Novolog (Pharm-Up 1966) had revenue of 373.25M in the quarter ending December 31, 2025, a decrease of -30.74%.
Revenue
1.81B
Revenue Growth
-10.70%
P/S Ratio
0.28
Revenue / Employee
1.97M
Employees
916
Market Cap
506.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.81B | -216.22M | -10.70% |
| Dec 31, 2024 | 2.02B | 378.11M | 23.01% |
| Dec 31, 2023 | 1.64B | 135.54M | 8.99% |
| Dec 31, 2022 | 1.51B | 252.70M | 20.13% |
| Dec 31, 2021 | 1.26B | 121.61M | 10.73% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 166.49M |
| Kamada | 575.31M |
| Bait Bakfar | 109.62M |
| Ilex Medical | 930.83M |
| Geffen Residence & Renewal | 78.00K |